Showing results (121-130 of 143) with videos related to
Sort By:
Pageof 15
JAMA|July 3, 2019
Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical TrialThomas J Schnitzer, Richard Easton, Shirley Pang, et al.Hypertension (Dallas, Tex. : 1979)|December 1, 1992
Discovery of a well-absorbed, efficacious renin inhibitor, A-74273H D Kleinert, H H Stein, S Boyd, et al.Annals of the Rheumatic Diseases|April 3, 2020
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up periodFrancis Berenbaum, Francisco J Blanco, Ali Guermazi, et al.The American Journal of Physiology|January 14, 1999
Gastrointestinal expression and partial cDNA cloning of murine Muc2B J van Klinken, A W Einerhand, L A Duits, et al.Journal of Pain Research|February 2, 2018
Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritisCharles Birbara, Eugene J Dabezies, Aimee M Burr, et al.The Journal of Rheumatology|October 3, 2014
Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxenEvan F Ekman, Joseph S Gimbel, Alfonso E Bello, et al.Pain Management|November 17, 2021
Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety studyShin-Ichi Konno, Takuya Nikaido, John D Markman, et al.Journal of Medicinal Chemistry|September 16, 1994
Nonpeptide renin inhibitors with good intraduodenal bioavailability and efficacy in dogS A Boyd, A K Fung, W R Baker, et al.Journal of the Neurological Sciences|February 26, 2022
Neurological safety of subcutaneous tanezumab versus NSAID in patients with osteoarthritisMark T Brown, Paola Sandroni, Phillip A Low, et al.Journal of Cardiovascular Pharmacology|January 1, 1993
Effects of high doses of A-74273, a novel nonpeptidic and orally bioavailable renin inhibitorK M Verburg, J S Polakowski, P J Kovar, et al.Pageof 15